Franklin Stuart Friedman

Insider Reports History

Entity
Individual
Location
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Franklin Stuart Friedman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Director Common Stock 0 $0 $15.62 Jun 11, 2024 Direct
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 Jun 11, 2024 Direct

Insider Reports Filed by Franklin Stuart Friedman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NA Deciphera Pharmaceuticals, Inc. Jun 11, 2024 6 $0 4 Jun 11, 2024 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 16, 2024 1 $50K 4 Jan 18, 2024 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 8, 2023 1 $139K 4 Jun 12, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 17, 2023 1 $50K 4 Jan 19, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 18, 2022 1 $50K 4 Jan 20, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Director